BusinessObjects Edge Series è una suite di prodotti di business intelligence semplici, collaudati e dal costo contenuto, realizzata appositamente per le aziende di piccole e medie dimensioni.
Consente di raggiungere lo stesso livello di comprensione dei dati aziendali e delle prestazioni tipico delle organizzazioni: dal reporting ad hoc flessibile ai cruscotti, dall'integrazione dei dati alla gestione delle prestazioni. E a costi nettamente ridotti.
BusinessObjects Edge Series 3.0
Questa suite globale destinata alle aziende di medie dimensioni offre soluzioni per ogni esigenza di BI: reporting di query e analisi ad hoc, cruscotti e visualizzazione, qualità e integrazione ottimali dei dati.
QuickStart BI Pack
Applicate rapidamente la BI alle applicazioni esistenti o alle esigenze specifiche del settore.

BusinessObjects Edge Series acts as a key enabler for Star Trac as they reach their growth targets.

Fuelquip New Zealand is one operating company of six under the "ECL Group". Fuelquip installs and services equipment for the fuel industry including tanks, pumps and environmental equipment. Fuelquip's core business of installation and maintenance services is based on a nationwide network of 17 service bases and workshops from which over 135 service vehicles operate. In addition a 38 seat call centre manages thousands of service and support requests each day.

A robust product line, enterprise-level reporting at midmarket prices, and sophisticated BI and training capabilities makes Business Objects the perfect fit for Sole Technology.

Logix is a VAD (Value Added Distributor), which distributes over a hundred computer brands throughout Europe. In France, about twenty of these brands are supplied exclusively to resellers who use them as the basis for their own software solution offerings to customers.

The Oscar Lambret Cancer Center in Lille was established in 1929 by Professor Oscar Lambret. The center now has 750 staff who provide specialist medical care for cancer patients, or carry out teaching and research work on cancer.
Stati Uniti e Canada: 1 866 681 3435
Europa: 00800 55 11 55 11
Elenco dei contatti